Sanofi (SNY) Shares Outstanding (2009 - 2026)
Sanofi's (SNY) quarterly Shares Outstanding (Entity) came in at $1.2 billion in Q4 2025, down 3.46% year-over-year from $1.3 billion in Q4 2024, and down 3.46% quarter-over-quarter from $1.3 billion in Q4 2024.
Analysis
Sanofi (SNY) Shares Outstanding (2009 - 2026) Analysis & Trends
Sanofi has disclosed Shares Outstanding (Entity) across 17 years of filings, most recently posting $1.2 billion for Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) fell 3.46% year-over-year to $1.2 billion; the TTM figure through Dec 2025 stood at $1.2 billion (down 3.46% YoY), while the FY2025 annual figure was $1.2 billion, down 3.46% from the prior year.
- Shares Outstanding (Entity) came in at $1.2 billion for Q4 2025 at Sanofi, down from $1.3 billion in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $1.3 billion in Q4 2023 to a low of $1.2 billion in Q4 2025.
- Average Shares Outstanding (Entity) over 5 years is $1.3 billion, with a median of $1.3 billion recorded in 2024.
- Year-over-year, Shares Outstanding (Entity) increased 1.03% in 2021 and decreased 3.46% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $1.3 billion in 2021, then fell by 0.22% to $1.3 billion in 2022, then increased by 0.31% to $1.3 billion in 2023, then retreated by 0.13% to $1.3 billion in 2024, then decreased by 3.46% to $1.2 billion in 2025.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $1.2 billion in Q4 2025, $1.3 billion in Q4 2024, and $1.3 billion in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 5.70 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 2.04 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 1.22 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | 210.89 Mn |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 111.58 Mn |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn | 200.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.22 Bn |
| Mar 31, 2026 | 1.22 Bn |
| Dec 31, 2025 | 1.22 Bn |
| Sep 30, 2025 | 1.22 Bn |
| Jun 30, 2025 | 1.22 Bn |
| Mar 31, 2025 | 1.25 Bn |
| Dec 31, 2024 | 1.25 Bn |
| Sep 30, 2024 | 1.25 Bn |
| Jun 30, 2024 | 1.25 Bn |
| Mar 31, 2024 | 1.25 Bn |
| Dec 31, 2023 | 1.25 Bn |
| Sep 30, 2023 | 1.25 Bn |
| Jun 30, 2023 | 1.25 Bn |
| Mar 31, 2023 | 1.25 Bn |
| Dec 31, 2022 | 1.25 Bn |
| Sep 30, 2022 | 1.25 Bn |
| Jun 30, 2022 | 1.25 Bn |
| Mar 31, 2022 | 1.25 Bn |
| Dec 31, 2021 | 1.25 Bn |
| Sep 30, 2021 | 1.25 Bn |